Gaps in Menopause Knowledge
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The average middle aged woman goes through a volatile period of endocrine fluctuations as she passes through menopause and the stages that precede and follow it. Ovarian hormones are steroid hormones. They readily cross the cell and nuclear membranes and influence transcription of numerous genes. Such influences are tissue specific and state specific. In short, changes in ovarian hormones mean that a women will experience changes in her entire body systems. When an individual woman’s constitutional factors, pathologic states, medications, environmental exposures are taken into consideration, the integrated changes become too complex to predict. Inter-study sampling differences with the complexities in the backdrop may have led to conflicting conclusions in menopause research. This paper reviews some of the controversies in the care of menopausal women. (J Menopausal Med 2014;20:47-51)
Abstract
The average middle aged woman goes through a volatile period of endocrine fluctuations as she passes through menopause and the stages that precede and follow it. Ovarian hormones are steroid hormones. They readily cross the cell and nuclear membranes and influence transcription of numerous genes. Such influences are tissue specific and state specific. In short, changes in ovarian hormones mean that a women will experience changes in her entire body systems. When an individual woman’s constitutional factors, pathologic states, medications, environmental exposures are taken into consideration, the integrated changes become too complex to predict. Inter-study sampling differences with the complexities in the backdrop may have led to conflicting conclusions in menopause research. This paper reviews some of the controversies in the care of menopausal women. (J Menopausal Med 2014;20:47-51)
참고문헌 (27)
- Beato M, "Interaction of steroid hormone receptors with the transcription initiation complex", Endocr Rev, 17, pp.587~609 (1996)
- Rubinow DR, "Neurobiology of mental illness", pp.544~555 (2009), Oxford University Press
- Arca M, "Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin", JAMA, 271, pp.453~459 (1994)
- Nakajima K, "Sex-related differences in response of plasma lipids to simvastatin: the Saitama Postmenopausal Lipid Intervention Study", Clin Ther, 21, pp.2047~2057 (1999)
- Wassertheil-Smoller S, "Depression and cardiovascular sequelae in postmenopausal women. The Women’s Health Initiative (WHI)", Arch Intern Med, 164, pp.289~298 (2004)
- Tatonetti NP, "Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels", Clin Pharmacol Ther, 90, pp.133~142 (2011)
- Schatz IJ, "Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study", Lancet, 358, pp.351~355 (2001)
- Culver AL, "Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative", Arch Intern Med, 172, pp.144~152 (2012)
- Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
- Manson JE, "Estrogen plus progestin and the risk of coronary heart disease", Med, 349, pp.523~534 (2003)
- Cushman M, "Estrogen plus progestin and risk of venous thrombosis", JAMA, 292, pp.1573~1580 (2004)
- "Wyeth stock falls 24% after report" (2002)[URL]
- "Pfizer paid $896 million in prempro settlements" (2012)[URL]
- Manson JE, "Estrogen therapy and coronary-artery calcification", Med, 356, pp.2591~2602 (2007)
- Mendelsohn ME, "HRT and the young at heart", Med, 356, pp.2639~2641 (2007)
- Grodstein F, "Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation", Womens Health (Larchmt), 15, pp.35~44 (2006)
- Haan MN, "Hormone therapy and age-related macular degeneration: the Women’s Health Initiative Sight Exam Study", Arch Ophthalmol, 124, pp.988~992 (2006)
- Newman-Casey PA, "The potential association between postmenopausal hormone use and primary open-angle glaucoma", JAMA Ophthalmol, 132, pp.298~303 (2014)
- Shumaker SA, "Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial", JAMA, 289, pp.2651~2662 (2003)
- Rapp SR, "Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial", JAMA, 289, pp.2663~2672 (2003)
- Craig MC, "Estrogen therapy and Alzheimer’s dementia", Acad Sci, 1205, pp.245~253 (2010)
- Kim T, "The effects of estrogen on the cognitive function and dementia", Korean Soc Menopause, 12, pp.103~112 (2006)
- Carcaillon L, "High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women", Neurology, 82, pp.504~511 (2014)
- Foster EA, "Adaptive prolonged postreproductive life span in killer whales", Science, 337, pp.1313~ (2012)
- Pollycove R, "The evolutionary origin and significance of menopause", Menopause, 18, pp.336~342 (2011)
- "OECD health data" (2013)[URL]
- 염선경, "한국 여성에서 폐경증상 중 혈관운동증상에 대한 역학 조사", 대한폐경학회지, 18(3), pp.147~154 (2012), 대한폐경학회